Holen Sie sich die Stockscreener-App
35.39
0.59%
-0.21
Handel nachbörslich:
35.39
Schlusskurs vom Vortag:
$35.60
Offen:
$35.17
24-Stunden-Volumen:
402.97K
Relative Volume:
0.82
Marktkapitalisierung:
$1.76B
Einnahmen:
$499.95M
Nettoeinkommen (Verlust:
$-36.36M
KGV:
-45.96
EPS:
-0.77
Netto-Cashflow:
$24.22M
1W Leistung:
+3.72%
1M Leistung:
+0.91%
6M Leistung:
+8.49%
1J Leistung:
+28.22%
1-Tages-Spanne:
$35.03
$36.00
1-Wochen-Bereich:
$34.13
$37.31
52-Wochen-Spanne:
$27.32
$43.11
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Vergleichen Sie ATRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
35.39 | 1.80B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
436.39 | 156.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.36 | 53.50B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.07 | 39.84B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.08 | 35.89B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
261.17 | 18.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
Analyzing AtriCure Inc. with multi timeframe chartsChart Signals & Entry Point Confirmation Alerts - newser.com
Will AtriCure Inc. see short term momentumTrade Risk Summary & Long-Term Safe Investment Ideas - newser.com
Is AtriCure Inc. stock trading near support levelsEntry Point & AI Powered Market Entry Ideas - newser.com
How to build a dashboard for AtriCure Inc. stockInsider Selling & Expert-Curated Trade Recommendations - newser.com
Applying Elliott Wave Theory to AtriCure Inc.July 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com
Momentum divergence signals in AtriCure Inc. chartWeekly Market Report & AI Optimized Trade Strategies - newser.com
Analyzing drawdowns of AtriCure Inc. with statistical toolsLong Setup & AI Forecasted Entry/Exit Points - newser.com
Did Analyst Optimism After Q3 Results Just Shift AtriCure's (ATRC) Path to Profitability Narrative? - simplywall.st
AtriCure, Inc. (NASDAQ:ATRC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Reversal indicators forming on AtriCure Inc. stockJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
AtriCure's (ATRC) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
AtriCure to Announce Third Quarter 2025 Financial Results - Business Wire
AtriCure, Inc.'s (NASDAQ:ATRC) Shift From Loss To Profit - 富途牛牛
AtriCure (NASDAQ:ATRC) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Marks Group Wealth Management Inc Increases Stock Position in AtriCure, Inc. $ATRC - MarketBeat
Order flow analysis tools used on AtriCure Inc.July 2025 Sector Moves & Verified Short-Term Plans - newser.com
Can AtriCure Inc. hit a new high this monthWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Is now a turning point for AtriCure Inc.July 2025 Catalysts & Real-Time Market Trend Scan - newser.com
Medtronic wins CE mark for Penditure LAA exclusion device - MedTech Dive
AtriCure (NASDAQ:ATRC) Trading Down 4.9%What's Next? - MarketBeat
Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial Fibrillation - American Heart Association Journals
What analysts say about AtriCure Inc stockFlag and Pennant Patterns & Wealth Building Starts With One Click - earlytimes.in
AtriCure, Inc. $ATRC Stake Reduced by Assenagon Asset Management S.A. - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
U.S. Cryoablation Devices Market Set to Witness Significant Growth by 2025-2032 - openPR.com
AtriCure to anchor Mason’s new bioscience corridor, add 25 jobs - soapboxmedia.com
What Are the Top 8 Left Atrial Appendage Closure Device Companies in 2025 and How Are They Shaping the Industry? - Global Growth Insights
AtriCure (ATRC) Valuation in Focus Following FDA Clearance and Launch of Next-Gen cryoXT Platform - Sahm
AtriCure, Inc. $ATRC Shares Sold by Rhumbline Advisers - MarketBeat
Will a bounce in AtriCure Inc. offer an exitJuly 2025 Review & Weekly High Potential Stock Alerts - newser.com
Is AtriCure's cryoXT FDA Clearance Reshaping the Investment Case for ATRC? - simplywall.st
First Bank & Trust Makes New Investment in AtriCure, Inc. $ATRC - MarketBeat
Street Watch: Will AtriCure Inc outperform the market in YEARJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - خودرو بانک
AtriCure, Inc. (NASDAQ:ATRC) Receives $50.89 Consensus Price Target from Analysts - MarketBeat
AtriCure, Inc. Experiences Evaluation Revision Amidst Mixed Market Signals and Performance Trends - Markets Mojo
CEO Moves: Will AtriCure Inc outperform the market in YEAR2025 Market Sentiment & Stock Market Timing Techniques - خودرو بانک
Justin J. Noznesky Sells 3,000 Shares of AtriCure (NASDAQ:ATRC) Stock - MarketBeat
Trend analysis for AtriCure Inc. this weekTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
Millennium Management LLC Has $20.11 Million Holdings in AtriCure, Inc. $ATRC - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $70.87 Million Stock Holdings in AtriCure, Inc. $ATRC - MarketBeat
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):